Search research articles
Contact Us
Filters
Showing results (1-10 of 45) with videos related to
Page
of 5
Sort By:
Current Opinion in Pharmacology
|
February 7, 2007
Sphingosine-1-phosphate signaling in the cardiovascular system
Stephan L M Peters, Astrid E Alewijnse
European Journal of Pharmacology
|
April 19, 2008
Sphingolipid signalling in the cardiovascular system: good, bad or both?
Astrid E Alewijnse, Stephan L M Peters
Cardiovascular Research
|
May 15, 2007
The RhoA/Rho kinase pathway in the myocardium
Stephan L M Peters, Martin C Michel
Trends in Pharmacological Sciences
|
July 28, 2006
Rho kinase: a target for treating urinary bladder dysfunction?
Stephan L M Peters, Martina Schmidt, Martin C Michel
Molecules and Cells
|
February 4, 2010
Sphingosine-1-phosphate receptors: zooming in on ligand-induced intracellular trafficking and its functional implications
Dennis Verzijl, Stephan L M Peters, Astrid E Alewijnse
British Journal of Pharmacology
|
October 27, 2004
Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites
Astrid E Alewijnse, Stephan L M Peters, Martin C Michel
European Heart Journal
|
March 27, 2007
Sphingomyelin metabolism and endothelial cell function
Arthur C M Mulders, Stephan L M Peters, Martin C Michel
Molecules and Cells
|
February 4, 2010
Sphingolipids and the orchestration of endothelium-derived vasoactive factors: when endothelial function demands greasing
Léon J A Spijkers, Astrid E Alewijnse, Stephan L M Peters
British Journal of Pharmacology
|
January 19, 2012
FTY720 (fingolimod) increases vascular tone and blood pressure in spontaneously hypertensive rats via inhibition of sphingosine kinase
Léon J A Spijkers, Astrid E Alewijnse, Stephan L M Peters
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
May 7, 2003
The influence of endogenously generated reactive oxygen species on the inotropic and chronotropic effects of adrenoceptor and ET-receptor stimulation
Carsten Sand, Stephan L M Peters, Martin Pfaffendorf, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 45) with videos related to
Sort By:
Page
of 5
Current Opinion in Pharmacology
|
February 7, 2007
Sphingosine-1-phosphate signaling in the cardiovascular system
Stephan L M Peters, Astrid E Alewijnse
European Journal of Pharmacology
|
April 19, 2008
Sphingolipid signalling in the cardiovascular system: good, bad or both?
Astrid E Alewijnse, Stephan L M Peters
Cardiovascular Research
|
May 15, 2007
The RhoA/Rho kinase pathway in the myocardium
Stephan L M Peters, Martin C Michel
Trends in Pharmacological Sciences
|
July 28, 2006
Rho kinase: a target for treating urinary bladder dysfunction?
Stephan L M Peters, Martina Schmidt, Martin C Michel
Molecules and Cells
|
February 4, 2010
Sphingosine-1-phosphate receptors: zooming in on ligand-induced intracellular trafficking and its functional implications
Dennis Verzijl, Stephan L M Peters, Astrid E Alewijnse
British Journal of Pharmacology
|
October 27, 2004
Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites
Astrid E Alewijnse, Stephan L M Peters, Martin C Michel
European Heart Journal
|
March 27, 2007
Sphingomyelin metabolism and endothelial cell function
Arthur C M Mulders, Stephan L M Peters, Martin C Michel
Molecules and Cells
|
February 4, 2010
Sphingolipids and the orchestration of endothelium-derived vasoactive factors: when endothelial function demands greasing
Léon J A Spijkers, Astrid E Alewijnse, Stephan L M Peters
British Journal of Pharmacology
|
January 19, 2012
FTY720 (fingolimod) increases vascular tone and blood pressure in spontaneously hypertensive rats via inhibition of sphingosine kinase
Léon J A Spijkers, Astrid E Alewijnse, Stephan L M Peters
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
May 7, 2003
The influence of endogenously generated reactive oxygen species on the inotropic and chronotropic effects of adrenoceptor and ET-receptor stimulation
Carsten Sand, Stephan L M Peters, Martin Pfaffendorf, et al.
Page
of 5